Clinical trials
Active, not recruiting Diabetes Mellitus, Type 2 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daewoong Pharmaceutical Co. LTD. | 3 |
| Amgen | 2 |
| Bayer | 2 |
| Dong-A ST Co., Ltd. | 1 |
| Kangbuk Samsung Hospital | 1 |
| Novo Nordisk A/S | 1 |
| ProGen. Co., Ltd. | 1 |
| Yonsei University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 12 |
| Obesity | 3 |
| Overweight | 2 |
| Renal Insufficiency, Chronic | 2 |
| Heart Failure | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.